Portfolio Alerts Watch List Cart

Pharmaceutical

Refine Search

Product Compare (0)
S
Sotac Pharmaceuticals Ltd
Score 48/100• Decent
Sotac Pharmaceuticals Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks and market sentiment.
Company’s Health89/100
Valuation 60/100 · PB 2.4561
Technical Avoid
1M 14.405% 6M 3.88% 1Y 5.142%
Confidence100%
No promoter pledgeReasonable PB valuation
Thin margins
#151
View details ➜
W
Welcure Drugs and Pharmaceuticals Ltd
Score 48/100• Risky
The stock shows potential in a growing sector but faces significant risks and inconsistencies in performance metrics.
Company’s Health45/100
Valuation 100/100 · PB 0.6642
Technical Avoid
1M -40.854% 6M -35.873% 1Y -21.196%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROE
#152
View details ➜
W
Wardwizard Healthcare Ltd
Score 48/100• Risky
Wardwizard Healthcare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health75/100
Valuation 100/100 · PB -0.2941
Technical Momentum
1M — 6M 97.53% 1Y 97.53%
Confidence100%
No promoter pledgeDecent revenue growth
Thin margins
#153
View details ➜
W
Wanbury Ltd
Score 48/100• Risky
Wanbury Ltd presents several risks with limited growth prospects and high valuation metrics, making it a risky investment at this time.
Company’s Health42/100
Valuation 20/100 · PB 15.4672
Technical Avoid
1M 0.961% 6M 9.676% 1Y 9.864%
Confidence100%
High debt/equityPromoter pledge present
#154
View details ➜
U
Unjha Formulations Ltd
Score 48/100• Decent
Unjha Formulations Ltd shows potential but faces challenges in execution and market sentiment.
Company’s Health61/100
Valuation 40/100 · PB 3.4246
Technical Avoid
1M -3.52% 6M 0.587% 1Y -20.16%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#155
View details ➜
S
Sunil Healthcare Ltd
Score 48/100• Risky
Sunil Healthcare Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
Company’s Health45/100
Valuation 80/100 · PB 1.0763
Technical Avoid
1M -8.037% 6M 1.911% 1Y -13.865%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEThin margins
#156
View details ➜
S
Soni Medicare Ltd
Score 48/100• Risky
Soni Medicare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health51/100
Valuation 20/100 · PB 36.0368
Technical Avoid
1M 1.596% 6M 40.627% 1Y 177.283%
Confidence100%
No promoter pledge
Weak ROEHigh debt/equity
#157
View details ➜
K
Kwality Pharmaceuticals Ltd
Score 48/100• Risky
Kwality Pharmaceuticals Ltd presents a mixed outlook with significant risks, particularly in execution and market sentiment.
Company’s Health90/100
Valuation 40/100 · PB 3.5322
Technical Avoid
1M -1.522% 6M 25.553% 1Y -4.147%
Confidence100%
Low leverage (D/E)No promoter pledge
#158
View details ➜
Z
Zota Health Care Ltd
Score 48/100• Risky
Zota Health Care Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health63/100
Valuation 20/100 · PB 20.4471
Technical Momentum
1M 10.807% 6M 69.442% 1Y 150.186%
Confidence100%
Decent revenue growth
Weak ROEPromoter pledge present
#159
View details ➜
W
Wockhardt Ltd
Score 48/100• Risky
Wockhardt Ltd presents several risks, particularly in growth consistency and balance sheet strength, making it a risky investment at this time.
Company’s Health30/100
Valuation 40/100 · PB 4.4714
Technical Avoid
1M -14.953% 6M -2.183% 1Y 6.054%
Confidence100%
Low leverage (D/E)
Weak ROEPromoter pledge present
#160
View details ➜
V
Vivo Bio Tech Ltd
Score 48/100• Risky
Vivo Bio Tech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health57/100
Valuation 100/100 · PB 0.9342
Technical Avoid
1M -14.367% 6M -11.716% 1Y -11.168%
Confidence100%
No promoter pledgeHealthy profit margins
Weak ROE
#161
View details ➜
V
Vivanza Biosciences Ltd
Score 48/100• Risky
Vivanza Biosciences Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health26/100
Valuation 80/100 · PB 1.9798
Technical Avoid
1M -3.922% 6M -10.909% 1Y -49.744%
Confidence100%
No promoter pledgeReasonable PB valuation
Weak ROEHigh debt/equity
#162
View details ➜
V
Vaidya Sane Ayurved Laboratories Ltd
Score 48/100• Risky
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health79/100
Valuation 20/100 · PB 5.1183
Technical Avoid
1M -5.923% 6M 106.489% 1Y 98.897%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#163
View details ➜
U
Unichem Laboratories Ltd
Score 48/100• Decent
Unichem Laboratories has a decent score, indicating potential but with notable risks and inconsistencies in growth and profitability.
Company’s Health68/100
Valuation 80/100 · PB 1.353
Technical Avoid
1M 2.831% 6M -20.002% 1Y -43.372%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#164
View details ➜
S
Sandu Pharmaceuticals Ltd
Score 48/100• Decent
Sandu Pharmaceuticals has a decent growth outlook but faces challenges in valuation and execution risks.
Company’s Health70/100
Valuation 80/100 · PB 1.0291
Technical Avoid
1M -5.376% 6M -11.436% 1Y -19.22%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#165
View details ➜
Showing 151 to 165 of 260 (18 Pages)